Kim LK - Search Results

1

Nonsystem reasons for delay in door-to-balloon time and associated in-hospital mortality: a report from the National Cardiovascular Data Registry.

Swaminathan RV, Wang TY, Kaltenbach LA, Kim LK, Minutello RM, Bergman G, Wong SC, Feldman DN. Swaminathan RV, et al. Among authors: kim lk. J Am Coll Cardiol. 2013 Apr 23;61(16):1688-95. doi: 10.1016/j.jacc.2012.11.073. Epub 2013 Mar 27. J Am Coll Cardiol. 2013. PMID: 23500264 Free article.

2

Chemotherapy-induced takotsubo cardiomyopathy.

Kim L, Karas M, Wong SC. Kim L, et al. J Invasive Cardiol. 2008 Dec;20(12):E338-40. J Invasive Cardiol. 2008. PMID: 19057042

3

Efficacy and safety of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention in current clinical practice.

Kim LK, Wong SC, Minutello RM, Bergman G, Feldman DN. Kim LK, et al. J Invasive Cardiol. 2010 Mar;22(3):94-100. J Invasive Cardiol. 2010. PMID: 20197573

4

Door-to-balloon time in primary percutaneous coronary intervention predicts degree of myocardial necrosis as measured using cardiac biomarkers.

Minutello RM, Kim L, Aggarwal S, Cuomo LJ, Feldman DN, Wong SC. Minutello RM, et al. Tex Heart Inst J. 2010;37(2):161-5. Tex Heart Inst J. 2010. PMID: 20401287 Free PMC article.

5

Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis.

Feldman DN, Kim L, Rene AG, Minutello RM, Bergman G, Wong SC. Feldman DN, et al. Catheter Cardiovasc Interv. 2011 Jun 1;77(7):1020-30. doi: 10.1002/ccd.22962. Epub 2011 May 13. Catheter Cardiovasc Interv. 2011. PMID: 21574239

6

Novel antiplatelet therapies.

Kim L, Charitakis K, Swaminathan RV, Feldman DN. Kim L, et al. Curr Atheroscler Rep. 2012 Feb;14(1):78-84. doi: 10.1007/s11883-011-0216-x. Curr Atheroscler Rep. 2012. PMID: 22102061 Review.

7

Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.

Gordin J, Haider A, Swaminathan RV, Kim LK, Minutello RM, Bergman G, Wong SC, Feldman DN. Gordin J, et al. Among authors: kim lk. Am J Cardiol. 2012 Nov 15;110(10):1397-404. doi: 10.1016/j.amjcard.2012.06.052. Epub 2012 Aug 2. Am J Cardiol. 2012. PMID: 22858186

8

Reperfusion therapy in ST-elevation myocardial infarction: guidelines, strategies, pharmacology, and stent selection.

Ghosh BD, Swaminathan RV, Kim LK, Feldman DN. Ghosh BD, et al. Among authors: kim lk. Minerva Med. 2012 Dec;103(6):431-9. Minerva Med. 2012. PMID: 23229365 Review.

9

Impact of peripheral vascular disease on short- and long-term outcomes in patients undergoing non-emergent percutaneous coronary intervention in the drug-eluting stent era.

Midwall S, Swaminathan RV, Charitakis K, Kim LK, Gordin J, Hriljac I, Minutello RM, Bergman G, Wong SC, Feldman DN. Midwall S, et al. Among authors: kim lk. J Invasive Cardiol. 2013 Mar;25(3):132-6. J Invasive Cardiol. 2013. PMID: 23468442 Free article.

10

Pharmacotherapy for the reduction of stent thrombosis.

Yang DC, Swaminathan RV, Kim LK, Feldman DN. Yang DC, et al. Among authors: kim lk. Expert Rev Cardiovasc Ther. 2013 May;11(5):567-76. doi: 10.1586/erc.13.34. Expert Rev Cardiovasc Ther. 2013. PMID: 23621139 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters